Maxime Dely: A Meaningful Journey of 14 years in Blood Transfusion
Maxime Dely, Therapeutic Solutions Sales Consultant at Terumo Blood and Cell Technologies, shared a post on LinkedIn:
“14 years in blood transfusion: a meaningful journey
It has already been 14 years since I started working in the field of blood transfusion.
Right after graduating, I had the opportunity to enter this demanding field directly, without imagining how much it would become a daily source of human
enrichment and scientific stimulation.
This profession means meeting people with unique life stories: patients, donors, physicians, nurses, caregivers… so many faces, cultures, and experiences that
constantly remind us of the strength of collective commitment.
At the heart of it all is this invisible link between a donor and a patient – no meeting, no words, yet a life-changing impact.
A remarkable form of silent solidarity
It is also a field in constant evolution: therapeutic innovations, new cell recovery techniques, continuous improvement of practices, and medical advances.
Each step reinforces my conviction that I work in an area where learning never stops.
Throughout this ‘short career,’ I have also had the chance to discover around thirty countries, explore fascinating cultures, and broaden both my view of the world and my profession.
The journey continues with the same curiosity, the same passion… and still just as much happiness.”
More posts featuring Maxime Dely on Hemostasis Today
-
Apr 3, 2026, 17:19Arun V J: Don’t Miss TRANSCON 2026 – A Direct Pathway Into India’s Clinical and Institutional Network
-
Apr 3, 2026, 17:17Louise St. Germain Bannon: Preparating for ISTH 2026 and Highlighting Best Aspects of Congress
-
Apr 3, 2026, 17:15Jeremy Jacobs: The Political Misuse of ‘Patient Autonomy’ in Modern Law
-
Apr 3, 2026, 17:14Yves Bikorimana: When More Is Not Better – Polycythemia
-
Apr 3, 2026, 17:14Congratulations to Vikram Huded On His New Role as The President of The Indian Stroke Association – Voice of Healthcare
-
Apr 3, 2026, 17:12Pedro Perez: Timing Is the Biggest Challenge in Treating DVT
-
Apr 3, 2026, 17:11Augustina Isioma Ikusemoro: Kell vs RhD Sensitization – The Difference in RBC Destruction
-
Apr 3, 2026, 17:06Pedro Perez: Has Computer-Assisted Thrombectomy Actually Improved Patient Care, Or Simply Improved the Tools?
-
Apr 3, 2026, 16:37Mavis Agnes Kisakye: From Advocacy to Action Strengthening Care for Bleeding Disorders in Uganda